ImmunoCellular Therapeutics (IMUC) 10-Q 2012 Q2 Quarterly report

Exhibit 10.1

CLIENT LICENSE AGREEMENT AMENDMENT

Re: License Agreement, dated as of 04/25/2011, by and between Immune Cellular Therapeutics, as Client and Regent Business Centers Woodland Hills, LLC, as Licensor.

The above referenced Agreement is hereby amended subject to the following modifications or revisions:

1. The term set forth in the Agreement is hereby extended. The renewal term will commence on07/01/2012and will expire on06/30/2013.

2. The Fixed Monthly Office Fee for the Office #3090/93/94/95 shall be$4,410.00subject to any modifications and/or revisions, which may be agreed to by both Regent and Client.

3. The contents of the Office as set forth in the License Agreement areunchanged.

4. Refundable Retainer in the amount of$44.00is required.

All capitalized terms used in this Agreement shall have the same meamng as set forth in and defined in the License Agreement.

Except as set forth herein, all other terms and conditions of the License Agreement shall remain in full force and effect.

Agreed to:

Dated:                        

ImmunoCellular Therapeutics, Ltd.

By:

Name:

Regent Business Centers Woodland Hills, LLC.

By:

Name: